Takeda Submits NDA for a Subcutaneous Formulation of Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis in Japan Read more
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer Healthcare Company Read more
Novartis Kisqali significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials Read more
Baxter Announces FDA Approval of Myxredlin, the First and Only Ready-To-Use Insulin for IV Infusion Read more
Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis Read more
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China Read more
MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation Read more
Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma Read more
Lynparza approved in Japan for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer Read more